Many experts say artificial intelligence and robots will displace jobs at a faster and faster pace over the coming decade. What changes in technology could mean for how we work.
Guest Host: Steve Roberts
Vioxx, antidepressants, and a new FDA drug safety board are all on the agenda as Steve Roberts leads a discussion about the Food and Drug Administration and how well it is protecting consumers.
- Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
- Marc Kaufman reporter on the national desk of "The Washington Post"
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
Most Recent Shows
The Koch Brothers are holding their annual meeting this weekend with hundreds of big donors in Southern California. But that's just one of the many ways the two influence money and politics. We look at the brothers' role in the 2016 presidential race and the latest on how the candidates are raising campaign cash.
Thousands of migrants try to reach Britain from France through the Channel Tunnel. Turkish airstrikes target Kurdish militants. And President Barack Obama wraps up a five-day trip to Africa. A panel of journalists joins guest host Susan Page for analysis of the week's top international news stories.
A white campus police officer in Cincinnati is charged with the murder of an unarmed black motorist. Congress passes interim funding for the highway bill. And the latest GDP report indicates modest second-quarter growth in the U.S. economy. A panel of journalists joins guest host Susan Page to round up the week's top news.